Research database

Vesicular Viral Vector Substitute (3VS) - Prototipazione e validazione di un dispositivo nanotecnologico vescicolare per terapia genica alternativa all’uso di vettori virali

Duration:
6 months (2023)
Principal investigator(s):
  • Tania Limongi
Project type:
Corporate-funded and donor-funded research
Funding body:
PRIVATI (Fondazione Compagnia di San Paolo)
Project identification number:
116208
PoliTo role:
Sole Contractor

Structures

Keywords

ERC sectors

LS7_3 - Pharmacology, pharmacogenomics, drug discovery and design, drug therapy
LS7_6 - Gene therapy, cell therapy, regenerative medicine
LS7_1 - Medical engineering and technology

Sustainable Development Goals

Obiettivo 3. Assicurare la salute e il benessere per tutti e per tutte le età

Budget

Total cost: € 50,000.00
Total contribution: € 50,000.00
PoliTo total cost: € 50,000.00
PoliTo contribution: € 50,000.00